Patent Terms Extended Under 35 U.S.C.   156
   
   A certificate extending the term of the following patent under 35
U.S.C.    156(d)(1) was issued on October 27, 1997:
   
   U.S. Patent No. 4,935,437; Granted June 19, 1990, to Philip N. Edwards,
et al.; Owner of Record: Zeneca Limited; Title: (SUBSTITUTED ARALKYL)
HETEROCYCLIC COMPOUNDS; Classification: 514/383; Product Trade Name:
ARIMIDEX  (anastrozole); Original Expiration Date: June 10, 2008; Term
Extended: 565 days, Extended Expiration Date: December 27, 2009.
   
   In addition, an order granting an interim extension of the term of the
following patent under 35 U.S.C.    156(e)(2) was issued on April 6,
1998:
   
   U.S. Patent No. 4,260,769; Granted April 7, 1981, to Valenino J. Stella
et al.; Owner of Record: Merck & Co., Inc.; Title:
5,5-DIPHENYLHYDANTOINS; Classification: 548/112; Product Trade Name:
CEREBYX  (fosphenytoin sodium); Original Expiration Date: April 7,
1998; Term Extended: One-Year.